As with many vector-borne, zoonotic diseases, the ecology of the pathogen– reservoir–vector cycle predisposes certain individuals to infection with Crimean- Congo hemorrhagic fever virus (CCHFV). Hence, there are several groups of individuals who are considered to be at risk of contracting Crimean-Congo hemorrhagic fever (CCHF), specifically, people from endemic areas who are susceptible to tick bite, particularly from Hyalomma spp. ticks. These include individuals who work outdoors, particularly those who work with large domestic animals. This fact was exemplified during a recent CCHF outbreak in Turkey where 90% of the infected patients were farmers [1]. Although CCHFV has been isolated from numerous species of ticks (see Chapter 12), those of the Hyalomma genus are considered the primary vector in CCHF enzootic and endemic areas. The distribution of CCHFV coincides precisely with the distribution of Hyalomma ticks [6]; therefore, there appears to be little or no risk in areas outside the known distribution of these ticks. Exposures such as crushing-infected ticks and butchering-infected animals have also been a frequent source of CCHFV infection. Other groups who are at risk include those caring for CCHF patients. In fact, the risk of nosocomial infection in health-care workers is well documented and can be extremely high. This can be exemplified by a nosocomial outbreak that occurred at Tygerberg Hospital in South Africa where 33% of the medical staff who had contact with CCHF patients through accidental needle sticks developed CCHF and another 8.7% contracted disease by other contacts with the patients’ blood [14]. Nosocomial infections with CCHFV will be discussed in greater detail in Chapter 21. In addition to health-care workers who care for CCHF patients, laboratory workers, and researchers working directly with the virus in the laboratory, or with infected vectors and/or animals, are at a higher risk of infection.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bakir M, Ugurlu M, Dokuzoguz B, Bodur H, Tasyaran MA, Vahaboglu H (2005) Crimean-Congo haemorrhagic fever outbreak in Middle Anatolia: a multicentre study of clinical features and outcome measures. J Med Microbiol 54:385–389.
Burney MI, Ghafoor A, Saleen M, Webb PA, Casals J (1980) Nosocomial outbreak of viral hemorrhagic fever caused by Crimean hemorrhagic fever-Congo virus in Pakistan, January 1976. Am J Trop Med Hyg 29:941–947.
Burt FJ, Swanepoel R (2005) Crimean-Congo hemorrhagic fever. In: Goodman JL, Dennis DT, Sonenshine DE (eds) Tick-Borne Diseases of Humans. ASM Press, Washington, DC, pp 164–175.
Fisher-Hoch SP, Khan JA, Rehman S, Mirza S, Khurshid M, McCormick JB (1995) Crimean Congo-haemorrhagic fever treated with oral ribavirin. Lancet 346:472–475.
Hassanain MA, El Garhy MF, Abdel-Ghaffar FA, El Sharaby A, Abdel-Mageed-Kadria N (1997) Biological control studies of soft and hard ticks in Egypt: I. The effect of Bacillus thuringiensis varieties on soft and hard ticks (Ixodidae) Parasitol Res 83:209–213.
Hoogstraal H (1979) The epidemiology of tick-borne Crimean-Congo hemorrhagic fever in Asia, Europe, and Africa. J Med Entomol 15:307–417.
Kalunda M, Lule M, Sekyalo E, Mukuye A, Mujomba E (1983) Virus isolation and identification. Rep East Afr Virus Res Inst 27:17–20.
Kondratenkov VF, Shevchenko SF, Perelatov VD, Badalov ME, Ionov SS, Semenov MY, Romanova VA, Lobanov VV, Tekut'ev IV (1970) Two year experiment on application of chemical campaign method against ixodid ticks in Crimean hemorrhagic fever focus of Rosov Oblast. Mater 3 Oblast Nauchn Prakt Konf (Rostov-on-Don, May 1970) p 157 (in Russian; in English, NAMRU3–T550).
Papa A, Bino S, Llagami A, Brahimaj B, Papadimitriou E, Pavlidou V, Velo E, Cahani G, Hajdini M, Pilaca A, Harxhi A, Antoniadis A (2002) Crimean-Congo hemorrhagic fever in Albania, 2001. Eur J Clin Microbiol Infect Dis 21:603–606.
Richmond JY, McKinney RW (1999) Biosafety in Microbiological and Biomedical Laboratories, 4th edn. US DHHS, Washington, DC.
Simpson DIH, Knight HEM, Courtois G, Williams MC, Weinbren MP, Kibukamusoke JW (1967) Congo virus: a hitherto undescribed virus occurring in Africa. I. Human isolations-clinical notes. East Afr Med J 44:87–92.
Sonenshine DE (1993) Biology of Ticks, vol. 2. Oxford University Press, New York.
Tkachenko EA, Butenko AM, Badalov ME, Zavodov TI, Chumakov MP (1971) Investigation of the immunogenic activity of killed brain vaccine against Crimean hemorrhagic fever. Tr Inst Polio Virusn Entsegalitov Akad Med Nauk SSSR 19:119–129 (in Russian; in English, NAMRU3–T931).
van Eeden PJ, van Eeden SF, Joubert JR, King JB, van de Wal BW, Michell WL (1985) A nosocomial outbreak of Crimean-Congo haemorrhagic fever at Tygerberg Hospital. Part II. Management of patients. S Afr Med J 68:718–721.
Vashkov V, Poleshchuk VD (1971) Measures for control of vectors of CHF-Hyalomma plumbeum plumbeum Panz. Ticks. Tr Inst Polio Virusn Entsefalitov Akad Med Nauk SSSR 19:239–244 (in Russian; in English, NAMRU3–T983).
Vasilenko SM (1973) Results of the investigation on etiology, epidemiologic features and the specific prophylactic of Crimean hemorrhagic fever (CHF) in Bulgaria. Abstract Inv Paper 9, International Congress on Tropical Medicine and Malaria, Athens, October 1973, vol 1, pp 32–33.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer
About this chapter
Cite this chapter
Whitehouse, C.A. (2007). Risk Groups and Control Measures for Crimean-Congo Hemorrhagic Fever. In: Ergonul, O., Whitehouse, C.A. (eds) Crimean-Congo Hemorrhagic Fever. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-6106-6_20
Download citation
DOI: https://doi.org/10.1007/978-1-4020-6106-6_20
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-6105-9
Online ISBN: 978-1-4020-6106-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)